Multidrug resistance-associated protein-1 (MRP1) genetic variants, MRP1 protein levels and severity of COPD

Abstract

Background: Multidrug resistance-associated protein-1 (MRP1) protects against oxidative stress and toxic compounds generated by cigarette smoking, which is the main risk factor for chronic obstructive pulmonary disease (COPD). We have previously shown that single nucleotide polymorphisms (SNPs) in MRP1 significantly associate with level of FEV1in two independent population based cohorts. The aim of our study was to assess the associations of MRP1 SNPs with FEV1level, MRP1 protein levels and inflammatory markers in bronchial biopsies and sputum of COPD patients.Methods: Five SNPs (rs212093, rs4148382, rs504348, rs4781699, rs35621) in MRP1 were genotyped in 110 COPD patients. The effects of MRP1 SNPs were analyzed using linear regression models.Results: One SNP, rs212093 was significantly associated with a higher FEV1level and less airway wall inflammation. Another SNP, rs4148382 was significantly associated with a lower FEV1level, higher number of inflammatory cells in induced sputum and with a higher MRP1 protein level in bronchial biopsies.Conclusions: This is the first study linking MRP1 SNPs with lung function and inflammatory markers in COPD patients, suggesting a role of MRP1 SNPs in the severity of COPD in addition to their association with MRP1 protein level in bronchial biopsies. © 2010 Budulac et al; licensee BioMed Central Ltd.